Uncategorized
Glaukos Announces Participation in J.P. Morgan Healthcare Conference
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its management is scheduled to participate in the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020, at 8:00 a.m. PST in San Francisco. A live audio webcast for this event will be available in the Investors section of th